PMC5117185_01
A.B. Microphotograph of the poorly differentiated
carcinoma with signet ring features. C. No immunohistochemistry staining was seen for
HER-2- Score 0 (Dako Polyclonal 1:400).
gr1.jpg
PMC5117185_01_gr1.jpg
fig0005
Fluorine-18 fluorodeoxyglucose Positron Emission
Tomography (18F-FDG PET) image (on the left) showed an area of
abnormal increased radiopharmaceutical uptake in the epigastrium (red arrow),
corresponding to the stomach wall at axial CT and fused PET/CT images (A),
respectively. 18F-FDG PET/CT also detected multiple hypermetabolic
lymphadenopathies (yellow arrows) in the cervical, thoracic and abdominopelvic
regions. In particular left cervical (B), left axillary (C) and bilateral external
iliac hypermetabolic lymphadenopathies (D) are showed at axial CT and fused PET/CT
images, respectively.
gr2.jpg
PMC5117185_01_gr2.jpg
fig0010
A CT-scan and positron-emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) detected an intense FDG-uptake in the gastric antrum and in the lymph nodal chains (Fig. 2).